Transdermal system (tds) that contain inhibitors of phosphodiesterase lV

The invention relates to a transdermal system that is characterized by a content in a phosphodiesterase IV inhibitor, especially (-) rolipram or (R)-(-)-5-(4-methoxyphenyl-3-propoxy)-5-methyl-2-oxazolidinone.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIPP RALPH, GUENTHER CLEMES, WINDT FRED
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a transdermal system that is characterized by a content in a phosphodiesterase IV inhibitor, especially (-) rolipram or (R)-(-)-5-(4-methoxyphenyl-3-propoxy)-5-methyl-2-oxazolidinone.